Sign in

CIK 0001980845 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

enGene Therapeutics Inc.

Sign in to watch
Ticker
ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Oct 31
Incorporated
Canada (Federal Level)
Entity type
operating
Phone
(514) 332-4888
Business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
Former names
enGene Holdings Inc.

Securities

  • ENGN Common Stock Nasdaq
  • ENGNW Warrants Nasdaq
  1. S-1 Offering Registration Statement
  2. 3 Insider Initial Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. SC 13D Stake Beneficial Ownership Report
  7. 8-K Event Executive or director change
  8. SC 13D Stake Beneficial Ownership Report
  9. 3 Insider Initial Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. 4 Other acquisition 10% owner acquired 2,392,436 shares (other)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Chief Technology Officer acquired 49,933 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 24,555 shares (grant or award)
  18. 4 Grant or award Director acquired 3,049,299 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 12 of 14 · 268 filings